About The Medicines Company
The Medicines Company is a global biopharmaceutical company. The Company's marketed products include Angiomax (bivalirudin), Cleviprex (clevidipine) injectable emulsion, Ionsys (fentanyl iontophoretic transdermal system), Kengreal (cangrelor), Minocin (minocycline) for injection, and Orbactiv (oritavancin). Its pipeline of acute and intensive care hospital products in development include ABP-700, ALN-PCSsc, Carbavance and MDCO-216. It sells a ready to use formulation of Argatroban and has a portfolio of over 10 generic drugs, which is referred as acute care generic products. It sells over three acute care generic products, including midazolam, ondansetron and rocuronium. The Company's products include Angiomax, which is a direct thrombin inhibitor; Cleviprex, which is a calcium channel blocker; Ionsys, which is a patient-controlled analgesia system; Kengreal, which is an antiplatelet agent; Minocin IV, which is a tetracycline-class antibiotic, and Orbactiv, which is an antibiotic.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Drugs - Generic
- Sub-Industry: Pharmaceuticals
- Exchange: NASDAQ
- Symbol: MDCO
- CUSIP: 58468810
- Previous Close: $52.06
- 50 Day Moving Average: $42.42
- 200 Day Moving Average: $38.01
- 52-Week Range: $29.48 - $54.01
- Trailing P/E Ratio: N/A
- Foreward P/E Ratio: -11.15
- P/E Growth: -0.51
- Market Cap: $3.65B
- Outstanding Shares: 70,194,000
- Beta: 0.5
- Net Margins: -96.44%
- Return on Equity: -35.07%
- Return on Assets: -14.80%
Companies Related to The Medicines Company:
- Debt-to-Equity Ratio: 0.81%
- Current Ratio: 3.46%
- Quick Ratio: 3.12%
What is The Medicines Company's stock symbol?
The Medicines Company trades on the NASDAQ under the ticker symbol "MDCO."
Where is The Medicines Company's stock going? Where will The Medicines Company's stock price be in 2017?
12 brokerages have issued 1 year target prices for The Medicines Company's stock. Their forecasts range from $45.00 to $65.00. On average, they anticipate The Medicines Company's share price to reach $53.13 in the next year.
When will The Medicines Company announce their earnings?
The Medicines Company is scheduled to release their next quarterly earnings announcement on Tuesday, February, 28th 2017.
Who owns The Medicines Company stock?
The Medicines Company's stock is owned by a number of of institutional and retail investors. Top institutional investors include FMR LLC (15.13%), State Street Corp (2.93%), Sarissa Capital Management LP (2.50%), Dimensional Fund Advisors LP (2.09%), Franklin Resources Inc. (2.03%) and Pinnacle Associates Ltd. (1.96%). Company insiders that own The Medicines Company stock include Armin M Kessler, Christopher T Cox, Clive Meanwell, Elizabeth H S Wyatt, Fredric N Eshelman, Glenn Sblendorio, Hiroaki Shigeta, Melvin K Spigelman, Robert G Savage, William Bernard O'connor and William Crouse.
Who sold The Medicines Company stock? Who is selling The Medicines Company stock?
The Medicines Company's stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, Federated Investors Inc. PA, Numeric Investors LLC, Fred Alger Management Inc., Dimensional Fund Advisors LP, Teachers Retirement System of The State of Kentucky, Guggenheim Capital LLC and Franklin Resources Inc.. Company insiders that have sold The Medicines Company stock in the last year include Armin M Kessler, Clive Meanwell, Elizabeth H S Wyatt, Hiroaki Shigeta, Melvin K Spigelman, William Bernard O'connor and William Crouse.
Who bought The Medicines Company stock? Who is buying The Medicines Company stock?
The Medicines Company's stock was bought by a variety of institutional investors in the last quarter, including Sarissa Capital Management LP, Iridian Asset Management LLC CT, Pinnacle Associates Ltd., Renaissance Technologies LLC, Marshall Wace LLP, RTW Investments LP, Frontier Capital Management Co. LLC and Broadfin Capital LLC. Company insiders that have bought The Medicines Company stock in the last two years include Christopher T Cox and Fredric N Eshelman.
How do I buy The Medicines Company stock?
Shares of The Medicines Company can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How much does a share of The Medicines Company stock cost?
One share of The Medicines Company stock can currently be purchased for approximately $52.06.